MBI 111 - Microorganisms and Human Disease |
Innate Host Defenses:
Resistance
Innate
host defense factors are non-specific immune (resistance) factors that are present before infection
... they work all the time and effective against many different kinds of microbes
- External resistance factors - those which act on
body surfaces
- Overview
- Physical
- Chemical - activities carried out by molecules
- Cellular - activities carried out by cells
- Details for Microbial Routes of Entry
- Skin Anatomy and Associated
Host Defense Factors
- epidermis - outer layer of skin (keratinized)
- physical - barrier, continually sloughing,
dry
- chemical - sebum (fatty acids, lipids); sweat
(salt, lysozyme)
- cellular - normal microbiota make acids (lactic,
etc.) that keep pH low
- dermis - inner layer of skin
- physical - barrier
- chemical - sebaceous glands (sebum) and sweat
glands (salt)
- cellular - phagocytes (PMN) and complement from
bloodstream
Respiratory Tract Anatomy and Associated
Host Defense Factors
- Upper
respiratory tract - nares (nostrils), oral cavity,
pharynx (throat)
- physical - sneezing, nasal hairs and mucus (filtration),
continual sloughing of epithelium, flushing of oral cavity
and pharynx by saliva
- chemical - enzymes in saliva, mucus
- cellular - phagocytes (PMN), normal microbiota
- Lower
respiratory tract - epiglottis, trachea, bronchi,
bronchioles, alveoli
- physical - coughing, ciliated mucosal epithelium
("mucus escalator")
- chemical - mucus, enzymes
- cellular - phagocytes (alveolar macrophages)
- Gastrointestinal Tract Anatomy and Associated
Host Defense Factors
- Oral cavity (mouth), pharynx (throat), esophagus
- physical - mucus, sloughing epithelium , saliva,
peristalsis
- chemical - enzymes in saliva, mucus
- cellular - normal
microbiota
- Stomach
- physical - mucus, sloughing epithelium,
peristalsis
- chemical - HCl (pH ~2), pepsin (digestive
enzyme)
- cellular - normal microbiota (?)
- Small intestine
- physical - mucus, sloughing epithelium,
peristalsis
- chemical - digestive enzymes (pancreas), bile
(gall bladder)
- cellular - normal microbiota
- Large intestine - includes colon, rectum and anus
- physical - mucus, sloughing epithelium,
peristalsis
- chemical - anaerobic conditions
- cellular - normal microbiota (100
billion bacteria per gram of fecal material in large
intestine)
- Genitourinary Anatomy and Associated
Host Defense Factors
- Urinary tract (male and female) - urethra, bladder,
ureters and kidneys
- physical - mucus, epithelium (barrier), flushing with
urine
- chemical - mucus, low pH of urine
- cellular - normal urethral
microbiota
- External genitalia (male and female)
- physical - barrier
- chemical - mucus, specialized sebaceous secretions
(smegma, etc.)
- cellular - normal microbiota
Genital tract (male) - urethra (see above), seminal
ducts
- physical - mucus; epithelium
- chemical - mucus
- cellular - phagocytes; normal urethral
microbiota
- Genital tract (female) - vagina, uterus, fallopian
tubes
- physical - mucus; multi-layered, continually-sloughing
epithelium
- chemical - mucus; low pH (lactic acid produced by normal
microbiota)
- cellular - phagocytes; normal microbiota (live on
sloughing epithelial cells, which contain glycogen) maintain
pH ~3-4
- Internal resistance factors - those which act within tissues
- physical - barriers such as connective
tissue, blood-brain
barrier
- chemical - activities carried out by molecules
- enzymes - lysozyme and other enzymes in blood and tissue fluids
- complement -
can be nonspecifically activated by bacterial and fungal polysaccharides or lipopolysaccharides
- cellular - activities carried out by cells
- inflammation - "early-warning" system
- histamine released
from mast cells at sites of tissue damage
- increases permeability of capillaries at these sites, causing accumulation
of complement, enzymes and phagocytes at sites of infection
- phagocytes eliminate pathogens and healing is initiated
- cardinal signs of inflammation - erythema (redness); edema (swelling); fever (heat); pain (soreness)
- phagocytosis -
process by which phagocytes (macrophages and polymorphonuclear
leukocytes, aka PMNs) engulf and destroy microbes
- adhesion (attachment) - phagocyte and pathogen bind to each other
- ingestion (engulfment) - pseudopodia surround
the pathogen, then fuse to form a vacuole called a phagosome
- killing and digestion - inside phagolysosomes,
which are formed by fusion of lysosomes with
phagosomes:
- egestion - release of non-digestible material by a process that is essentially
the reverse of ingestion
Adaptive Host Defenses: Immunity
Adaptive
host defense factors are immune factors that are triggered by antigens,
substances produced by microbes during infection, and are specific for those pathogens
to which one is exposed
- Antibody-mediated immunity (AMI)
- antibody
responses
- antibody is
produced by B cells (lymphocytes) stimulated by T cells in response to antigens made
by infectious agents
- Phagocytes called antigen
presenting cells (APCs) engulf, process and present fragments
of antigen molecules on their surfaces
- Lymphocytes called T
helper (Th) cells recognize (using antigen receptors on their surfaces)
antigen fragments, then proliferate and differentiate to form a large population
of cytokine-producing Th cells
- Lymphocytes called B
cells bind antigen (using antigen receptors on their surfaces) and bind
cytokines (using cytokine receptors on their surfaces), then proliferate and
differentiate to form a large population of antibody-producing plasma cells
- antibody binds specifically to the antigen that induced its formation
- mechanisms of action (ways in which AMI functions)
- neutralization - inhibition of toxin function, viral infectivity, microbe attachment
due to antibody binding to surface antigens of pathogens
- antibody/complement-mediated
lysis - complement is activated by binding to antibody molecules that have
bound to antigens, and causes lysis of microbes via formation of a membrane
attack complex (MAC)
- opsonization - antibody and complement both enhance attachment of pathogens
to phagocytes via receptors that bind them
- Cell-mediated immunity (CMI)
- cellular responses
- cytotoxic T lymphocytes (CTLs) are activated by T helper cells in the
presence of viral antigens on virus-infected cells
- Phagocytes called antigen
presenting cells (APCs)engulf, process and "present" fragments
of antigen molecules on their surfaces
- Lymphocytes called T
helper (Th) cells cells recognize (using antigen receptors on their surfaces)
antigen fragments, then proliferate and differentiate to form a large population
of cytokine-producing Th cells
- Lymphocytes called Tc
cells (CTL precursor
cells) bind antigen (using antigen receptors on their surfaces) and bind Th
cell-produced cytokines (using cytokine receptors on their surfaces),
then proliferate and differentiate to form a large population of CTLs
- macrophages are also activated by T helper cells
- APCs engulf, process and "present"
fragments of antigen molecules on their surfaces
- Th cells recognize (using antigen receptors on their surfaces) antigen
fragments, then proliferate and differentiate to form a large population of cytokine-producing
Th cells
- macrophages bind Th cell-produced cytokines (using cytokine receptors
on their surfaces), then differentiate to form activated macrophages
- mechanisms of action (ways in which CMI functions)
Coping Strategies
Vaccines are
killed or attenuated (weakened) preparations containing microbial antigens that are used to stimulate
immune responses without causing disease
- Types of vaccines
- toxoid vaccines - a chemically inactivated toxin that is used to induce production
of neutralizing antibody
- killed vaccines - chemically inactivated microbe used to induce antibody production
- whole microbe vaccines - include the entire microbe
- split microbe vaccines - include only the antigens needed to induce antibody responses
- live attenuated vaccines - living, but less virulent, microbe causes a transient infection
that leads to generation of both AMI and CMI
- recombinant vaccines
- vector vaccines are those generated by incorporating antigen genes isolated
from pathogens into non-harmful bacteria or viruses
- food vaccines are those generated by incorporating genes for microbial antigens
into foods such as bananas or tomatoes
- DNA vaccines - injection of DNA containing genes that code for microbial antigens
can lead to transient expression of those genes, resulting in immunization of the host
- Childhood
immunizations (vaccinations)
- Hepatitis B - vaccinate within 2 months after birth; boost
1 month later; boost again 2 months after the second dose (and 4 months after the first
dose); if not vaccinated earlier, assess immunity, then vaccinate as needed at 11-12 years
of age
- DTaP (diphtheria, pertussis, tetanus) - vaccinate with DTaP vaccine
at 2, 4, 6,15-18 months, then boost at age 4-6 years; Td vaccine (no pertussis component) is
used as a booster at age 11-16, then every 7-10 years after that
- hepatitis A - vaccinate at 2-12 years of age in areas where high
risk of infection occurs; especially recommended for children living in communities with high
rates of hepatitis A (vaccination helps prevent carrier state as well as outright disease)
- Hib (Haemophilus influenza b) - vaccinate at 2, 4, 6,
and 12-15 months
- poliomyelitis - injectable polio vaccine (IPV) at 2,
4 and 6-18 months; boost at 4-6 years (the oral polio vaccine (OPV) is no longer recommended
in the US because it causes the very small number of cases (~4 cases from 1997-1998) of polio
in this country
- MMR (measles, mumps, rubella) - vaccinate at 12-15 months; boost
at 4-6 years of age; if not vaccinated earlier, assess immunity, then vaccinate as needed at11-12
years of age; populations that don't get vaccine have Congenital Rubella Syndrome
- varicella (chickenpox) - vaccinate at 12-18 months; if
not vaccinated earlier, assess immunity, then vaccinate as needed at 11-12 years of age (or up
to 18)
- Other immunizations (vaccinations)
- Menomune induces immunity against major strains of Neisseria
meningitidis, the major cause of meningitis in college-age people; currently recommended
for first-year college students, especially those living in dorms
- Prevnar -
induces immunity to the 7 major strains of Streptococcus pneuminiae, which causes middle
ear infections and meningitis in children and pneumonia in all age groups; it is given as a four
dose series, starting at two months of age (with a minimum of 6 weeks of age); subsequent doses
are given at age four months and six months of age, with a fourth dose at age 12-15 months (and
at least two months after the third dose); recommended that all children under age 23 months be
given this vaccine; adults 65 and over are recommended to get this vaccine as well
- Rotashield is
a newly-formulated oral vaccine aimed at preventing diarrheal disease (rotavirus causes at ~55,000
hospital admissions and 20-40 infant deaths each year in the US, and is a major cause of death
in developing nations, where it causes >600,000 deaths each year)
- Smallpox vaccine, used to eradicate smallpox worldwide in 1977, is no longer used outside
of research environments, but millions of doses have been generated since September 11, 2001, as
a possible "hedge" against bioterrorist attack
Disinfection
- sterilant - agent that kills all
microorganisms
- germicide - a chemical agent that kills
harmful microorganisms
- disinfectant - used only on environmental
surfaces because it is too harsh to be used on
human skin
- antiseptic - can be used on human skin
because it is rather mild
- incineration - direct flame burns microorganisms;
destructive, but sterilizes
- hot-air oven - dry heat, doesn't penetrate
well; takes a long time to sterilize; works only on
heat-stable objects
- boiling - moist heat disinfects, but
takes a long time to penetrate
- autoclaving - moist heat under
pressure (15-30 minutes at 121C and 15 psi)
sterilizes solids or heat-stable liquids
- pasteurization - moderately high heat and for short
exposure time disinfects liquids (milk, beer, wine,
etc.) that would be destroyed by other methods; heating to 72C
for 15 seconds or 82C for 3 seconds is effective
- radiation
- ultraviolet (UV) light - disinfects only
on thin films or surfaces
- ionizing radiation (X-rays, gamma rays) -
sterilizes many substances (plastics, cloth,
etc.)
- filtration - disinfects liquids or
gasses
Antimicrobial Chemotherapeutic Agents (CTAs)
- origin
- antibiotics are naturally occurring substances
made by certain bacteria and fungi (these can be modified
chemically, as well)
- antimetabolites are synthetic substances made
from chemicals by humans in factories
- mechanisms of action - CTAs work by damaging:
- metabolites (required for energy-generating
reactions in cells) - sulfa drugs, INH (isoniazid)
- membranes - nystatin, polymyxin B
- cell walls - penicillin, cephalosporin,
bacitracin, vancomycin
- protein synthesis - streptomycin, tetracycline,
chloramphenicol
- nucleic acid synthesis - naladixic acid,
novobiocin, rifampin
- Considerations for use of CTAs
- spectrum - indicates the variety of microbes killed; broad-spectrum CTAs kill many
different microbes and may be preferred because of this
- selective toxicity - a selectively toxic agent is harmful to one living thing (e.g.,
microbe) but not to another (e.g., host)
- effectiveness - CTAs must be administered by an appropriate route so they
can reach infected sites in an appropriate concentration to act against the
organism(s) within their spectrum
- susceptibility of microbe - if a microbe is killed or its growth inhibited by an
antimicrobial CTA, it is said to be sensitive to that CTA; microbial resistance to
an antimicrobial CTA is an undesirable lack of sensitivity to that CTA:
- resistance can be acquired by a microbe via a mutation
or acquisition of resistance genes (on plasmids)
- testing bacterial and fungal cultures for antibiotic sensitivity is very important
for proper therapy of infected persons due to the possibility of resistance
- allergenic potential - the CTA must not induce allergic (hypersensitivity) reactions
in the host because this can be uncomfortable, and might even be life-threatening in some
cases
Did ya know...?
More than 133 million antibiotic prescriptions are written by US doctors each year to ambulatory patients and ~190 million doses of antibiotics are administered each day
© 1995-2013 John R. Stevenson. All Rights
Reserved
Please email
questions and comments to:
John
R. Stevenson, Ph.D.
Associate Professor
Department of Microbiology
Miami University
Oxford, Ohio 45056
USA
This document was last modified on Thursday, 20-Dec-2012 17:31:38 EST